Malignant Peritoneal Neoplasm Terminated Phase 1 Trials for Alemtuzumab (DB00087)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00637390A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.Treatment